Shares of US drug developer Denali Therapeutics closed up 5.8% at $20.11 yesterday, after it announced a $275 million ...
The basal cell carcinoma market is expected to expand over the next decade as rising diagnoses, aging populations and ...
Ireland incorporated Cosmo Pharmaceuticals saw its shares rise more than 3% to $91.80 yesterday, after it announced ...
US biotech Vanda Pharmaceuticals (Nasdaq: VNDA) has announced that the American medicines regulator removed a partial ...
The US Food and Drug Administration has approved Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19 ...
A Netherlands-linked biotech company developing targeted protein degraders designed to remove disease-relevant membrane ...
US oncology specialist Crescent Biopharma has announced an exclusive partnership with China’s Sichuan Kelun-Biotech ...
Accession Therapeutics, a UK clinical-stage biopharmaceutical company developing next generation cancer immunotherapies, ...
The UK’s BioIndustry Association (BIA) today released its report, From innovation to impact: unlocking patient access to ...
The US Food and Drug Administration (FDA) has announced that Tracy Beth Høeg has been appointed acting director of the Center ...
A new Australian biotech, Evinco Therapeutics, has launched in Melbourne to advance immune-based treatments for Alzheimer’s ...
Germany’s Formycon and Jordan-based MS Pharma have entered into an exclusive licensing and supply agreement for the commercialization of FYB206, Formycon’s biosimilar candidate to the blockbuster drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback